Parameter | Spontaneous cerebellar hemorrhage (N = 155) | % |
---|---|---|
Age (y), Median (range) | 66 (18–87) | |
Male | 84 | 54.2 |
Initial heart rate, Median (IQR) | 85 (72, 98) | |
Initial systolic blood pressure (mmHg), Median (IQR) | 166 (142, 195) | |
Initial diastolic blood pressure (mmHg), Median (IQR) | 90 (76, 101) | |
Body temperature, Median (IQR) | 36.5 (36, 36.9) | |
Body mass index, Median (IQR) | 23.7 (20.7, 25.8) | |
GCS at admission | ||
4–8 | 34 | 21.9 |
9–12 | 18 | 11.6 |
13–15 | 103 | 66.5 |
Pupil had light reflex | 130 | 83.9 |
Underlying diseases | – | |
Hypertension | 122 | 78.7 |
Diabetes mellitus | 44 | 28.4 |
Liver cirrhosis | 9 | 5.8 |
Atrial fibrillation | 10 | 6.5 |
Coronary artery disease | 5 | 3.2 |
Valvular heart disease | 11 | 7.1 |
Old cerebral vascular accidents | 30 | 19.4 |
End stage renal disease | 10 | 6.5 |
Alcoholism | 16 | 10.3 |
Smoking | 19 | 12.3 |
Anti-coagulation medications | ||
Aspirin | 8 | 5.2 |
Warfarin | 2 | 1.3 |
Laboratory data at presentation, Median (IQR) | – | |
WBC (X103/mL) | 9.9 (7.2, 13.2) | |
Platelet counts (X103/mL) | 193 (143, 230) | |
Prothrombin time (seconds) | 10.4 (10, 11.1) | |
International normalized ratio (INR) | 1.0 (0.94, 1.08) | |
Creatinine, mg/dL | 0.98 (0.77, 1.27) | |
Aspartate transaminase (AST), (IU/L) | 30 (24, 43) | |
Alanine transaminase (ALT), (IU/L) | 23 (17, 35) | |
Blood sugar, mmol/L | 151 (129, 202) | |
Signs and symptoms at onset | – | |
Headache | 60 | 38.7 |
Nausea, vomiting | 90 | 58.1 |
Unsteady gait | 20 | 12.9 |
Loss of consciousness | 41 | 26.5 |
Limbs weakness | 5 | 3.2 |
Symptoms duration (days) | 1.5 (1.0, 4.0) |